REVB Revelation Biosciences reports vastly wider Q4 2025 loss than estimates shares end flat for the trading day INTT inTest Corporation Q4 2025 EPS outperforms consensus estimates shares rise 674 percent on positive investor reaction BLW Blackrock emphasizes targeted fixed income positioning to deliver stable returns across coming reporting quarters